L. Fananapazir

发表

Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle

I. Rayment, K. Poetter, He Jiang, 1996, Nature Genetics.

A Fourier based algorithm for tracking SPAMM tags in gated magnetic resonance cardiac images.

M. A. Douglas, V. Dilsizian, L. Yaroslavsky, 1996, Medical physics.

Contribution of heart rate to QT interval shortening during exercise.

E. Faragher, D. Bennett, L. Fananapazir, 1983, European heart journal.

Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy.

A. Arai, L. Fananapazir, V. Sachdev, 2005, American heart journal.

Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients.

R O Bonow, C. Tracy, R. Bonow, 1989, Circulation.

Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis

A. Monaco, M. Brin, J. Volkmann, 2002, European Journal of Human Genetics.

Prevalence of hypertrophic cardiomyopathy and limitations of screening methods.

L. Fananapazir, N. Epstein, 1995, Circulation.

Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations.

N. Alpert, L. Fananapazir, D. Warshaw, 2005, American journal of physiology. Heart and circulatory physiology.

Modification of human hearing loss by plasma-membrane calcium pump PMCA2.

L. Fananapazir, A. Griffith, A. R. Penheiter, 2005, The New England journal of medicine.

Echocardiographic left ventricular dimensions in two groups of road race cyclists during a training season

J. White, L. Fananapazir, B. Ryan-Woolley, 1982 .

Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy.

C. Tracy, R. Bonow, M. Leon, 1991, The American journal of cardiology.

Efficacy of Implantable Cardioverter Defibrillator Therapy for Primary and Secondary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

L. Fananapazir, D. Begley, S. Mohiddin, 2003, Pacing and clinical electrophysiology : PACE.

Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries.

A. Quyyumi, R. Gracely, R. Cannon, 1990, Journal of the American College of Cardiology.

Ventilatory efficiency and resting hemodynamics in hypertrophic cardiomyopathy.

R. Arena, L. Fananapazir, D. Mcareavey, 2008, Medicine and science in sports and exercise.

Importance of preexcited QRS morphology during induced atrial fibrillation to the diagnosis and localization of multiple accessory pathways.

E. Prystowsky, J. Lowe, L. Fananapazir, 1990, Circulation.

Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest.

S. Epstein, L. Fananapazir, S. Epstein, 1991, The American journal of cardiology.

Chorein detection for the diagnosis of chorea‐acanthocytosis

A. Monaco, A. Lang, A. Danek, 2004, Annals of neurology.

Hypertrophic Cardiomyopathy Myocardial Perfusion and Sympathetic Innervation in Patients With Hypertrophic Cardiomyopathy

D. Goldstein, L. Fananapazir, C. Tack, 2016 .

Procainamide infusion test: inability to identify patients with Wolff-Parkinson-White syndrome who are potentially at risk of sudden death.

E. Prystowsky, D. Packer, L. Fananapazir, 1988, Circulation.

Impact of Surgical Relief of Outflow Obstruction on Thallium Perfusion Abnormalities in Hypertrophic Cardiomyopathy

V. Dilsizian, R. Bonow, R. Wallace, 1992, Circulation.

Myocardial Metabolic, Hemodynamic, and Electrocardiographic Significance of Reversible Thallium‐201 Abnormalities in Hypertrophic Cardiomyopathy

A. Quyyumi, V. Dilsizian, R. Bonow, 1991, Circulation.

Novel association of hypertrophic cardiomyopathy, sensorineural deafness, and a mutation in unconventional myosin VI (MYO6)

L. Fananapazir, T. Friedman, S. Mohiddin, 2004, Journal of Medical Genetics.

Reliability of the Evoked Response in Determining the Paced Ventricular Rate and Performance of the QT or Rate Responsive (TX) Pacemaker

D. Bennett, L. Fananapazir, M. Rademaker, 1985, Pacing and clinical electrophysiology : PACE.

Comparison of Resting Hemodynamic Indices and Exercise Performance During Atrial Synchronized and Asynchronous Ventricular Pacing

D. Bennett, L. Fananapazir, V. Srinivas, 1983, Pacing and clinical electrophysiology : PACE.

Urinary β‐Thromboglobulin in Essential Hypertension

L. Fananapazir, J. Dawes, J. Anderton, 1980 .

Electrophysiologic Studies in Patients with Hypertrophic Cardiomyopathy: Safety and Relation of Results to Clinical Findings

L. Fananapazir, 1990 .

Myocardial bridging in adult and pediatric patients with hypertrophic cardiomyopathy is not associated with poor outcome.

L. Fananapazir, S. Mohiddin, 2004, Journal of the American College of Cardiology.

Dual Chamber Pacemaker Therapy for Mid‐Cavity Obstructive Hypertrophic Cardiomyopathy

L. Fananapazir, D. Begley, S. Mohiddin, 2001, Pacing and clinical electrophysiology : PACE.

Long-Term Follow-Up of Children and Adolescents Diagnosed with Hypertrophic Cardiomyopathy: Risk Factors for Adverse Arrhythmic Events

E. Leifer, L. Fananapazir, J. Moak, 2011, Pediatric Cardiology.

Hypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death.

L. Fananapazir, D. Mcareavey, 1997, Pacing and clinical electrophysiology : PACE.

Obstructive hypertrophic cardiomyopathy.

L. Fananapazir, D. Tripodi, L. Hathaway, 2004, Progress in cardiovascular nursing.

Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease.

L. Fananapazir, D. Begley, S. Mohiddin, 2000, Journal of the American College of Cardiology.

Systolic compression of epicardial coronary and intramural arteries in children with hypertrophic cardiomyopathy.

L. Fananapazir, S. Mohiddin, 2002, Texas Heart Institute journal.

Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy: Reply

L. Fananapazir, S. Mohiddin, J. Shih, 2001 .

Genetic evidence of dissociation (generational skips) of electrical from morphologic forms of hypertrophic cardiomyopathy.

L. Fananapazir, N. Epstein, H. J. Lin, 1990, The American journal of cardiology.

Is functional capacity related to left atrial contractile function in nonobstructive hypertrophic cardiomyopathy?

A. Arai, L. Fananapazir, V. Sachdev, 2005, Congestive heart failure.

Myocardial bridging in children with hypertrophic cardiomyopathy.

L. Fananapazir, D. Begley, S. Mohiddin, 1999, The New England journal of medicine.

Right ventricular dysfunction and surgical outcome in postinfarction ventricular septal defect.

C. Bray, L. Fananapazir, J. Dark, 1983, European heart journal.

Structural and functional responses of mammalian thick filaments to alterations in myosin regulatory light chains.

J. Stull, L. Fananapazir, N. Epstein, 1998, Journal of structural biology.

Comparison of oxyfedrine and atenolol in angina pectoris--a double-blind study.

C. Bray, L. Fananapazir, 1985, British journal of clinical pharmacology.

Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.

L. Fananapazir, M. Gollob, R. Lozado, 2001, The New England journal of medicine.

Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.

L. Fananapazir, M. Gollob, R. Lozado, 2001, The New England journal of medicine.

Mutations of MYO6 are associated with recessive deafness, DFNB37.

L. Fananapazir, S. Riazuddin, Z. Ahmed, 2003, American journal of human genetics.

Evidence of Genetic Heterogeneity in Five Kindreds With Familial Hypertrophic Cardiomyopathy

J. Lalouel, R. Lifton, L. Fananapazir, 1992, Circulation.

Genotype-Phenotpe Correlations in Hypertrophic Cardiomyopathy Insights Provided by Comparisons of Kindreds With Distinct and Identical j3-Myosin Heavy Chain Gene Mutations

L. Fananapazir, N. Epstein, 2005 .

THE POSSIBLE RELATION BETWEEN LATE PREGNANCY HYPERTENSION AND 5‐HYDROXYTRYPTAMINE LEVELS IN MATERNAL BLOOD

L. Fananapazir, T. Crawford, I. Jelen, 1979, British journal of obstetrics and gynaecology.

Effect of intravenous magnesium sulfate on blood magnesium parameters.

L. Fananapazir, R. Elin, J. Hosseini, 1990, Magnesium and trace elements.

Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.

I. Rayment, J. Sellers, L. Fananapazir, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy.

L. Fananapazir, M. Ackerman, T. Doan, 2000, Journal of molecular and cellular cardiology.

Cardiac Involvement in the Neuroacanthocytosis Syndromes

L. Fananapazir, S. Mohiddin, 2004 .

Early clinical heterogeneity in choreoacanthocytosis.

A. Monaco, N. Gadoth, L. Fananapazir, 2005, Archives of neurology.

Hypertrophic Cardiomyopathy Caused by a Novel &agr;-Tropomyosin Mutation (V95A) Is Associated With Mild Cardiac Phenotype, Abnormal Calcium Binding to Troponin, Abnormal Myosin Cycling, and Poor Prognosis

E. Homsher, A. Arai, L. Fananapazir, 2001, Circulation.

Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy.

B. Maron, L. Fananapazir, J. Panza, 1992, Journal of the American College of Cardiology.

Echocardiographic detection of perforation of the cardiac ventricular septum by a permanent pacemaker lead.

R. Halvorsen, L. Fananapazir, J. Heinsimer, 1987, The American journal of cardiology.

Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene.

J. Minna, M. Wei, M. Lerman, 2004, The American journal of pathology.

Hypertrophic Cardiomyopathy: valuation and Treatment of Patients at High Risk for Sudden Death

L. Fananapazir, D. Mcareavey, 1997 .

Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.

W. Zhu, J. Sellers, L. Fananapazir, 1993, The Journal of clinical investigation.

Utility of genetic screening in hypertrophic cardiomyopathy: prevalence and significance of novel and double (homozygous and heterozygous) beta-myosin mutations.

J. Sellers, L. Fananapazir, D. Begley, 2003, Genetic testing.

Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations.

H Calkins, H. Calkins, R. Berger, 2000, Circulation.

Advances in molecular genetics and management of hypertrophic cardiomyopathy.

L. Fananapazir, 1999, JAMA.

Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms.

L. Fananapazir, D. Mcareavey, 1998, Journal of the American College of Cardiology.

Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure.

George C Tseng, Paul D Allen, Lameh Fananapazir, 2002, Physiological genomics.

Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.

M. Dalakas, L. Fananapazir, N. Epstein, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Minimum steriod requirements in renal transplant patients monitored by urinary fibrin degradation products and complement.

L. Fananapazir, J. Anderton, M. Eccleston, 1977, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Ventricular septal defect after myocardial infarction: assessment by cross sectional echocardiography with pulsed wave Doppler scanning.

L. Fananapazir, D. Macleod, P. Bloomfield, 1987, British heart journal.

Impact of Surgical Relief of Outflow Obstruction

V. Dilsizian, R. Wallace, P. O'Gara, 2005 .

Results of permanent dual-chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy.

D Tripodi, V. Dilsizian, R. Cannon, 1994, The American journal of cardiology.

Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy.

L. Fananapazir, D. Mcareavey, Dorothea McAreavey, 1992, The American journal of cardiology.

Differences in Clinical Expression of Hypertrophic Cardiomyopathy Associated With Two Distinct Mutations in the β‐Myosin Heavy Chain Gene: A 908Leu→Val Mutation and a 403Arg→gGln Mutation

L. Fananapazir, N. Epstein, G. Cohn, 1992, Circulation.

Impact of Dual‐Chamber Permanent Pacing in Patients With Obstructive Hypertrophic Cardiomyopathy With Symptoms Refractory to Verapamil and β‐Adrenergic Blocker Therapy

D Tripodi, R. Cannon, L. Fananapazir, 1992, Circulation.

Long‐term Results of Dual‐Chamber (DDD) Pacing in Obstructive Hypertrophic Cardiomyopathy: Evidence for Progressive Symptomatic and Hemodynamic Improvement and Reduction of Left Ventricular Hypertrophy

D Tripodi, L. Fananapazir, N. Epstein, 1994, Circulation.

Prognostic Determinants in Hypertrophic Cardiomyopathy: Prospective Evaluation of a Therapeutic Strategy Based on Clinical, Holter, Hemodynamic, and Electrophysiological Findings

S. Epstein, L. Fananapazir, D. Mcareavey, 1992, Circulation.

Non-sustained ventricular tachycardia on holter is notof prognostic significance in asymptomatic patients with hypertrophic cardiomyopathy

S. Epstein, L. Fananapazir, A. Chang, 1991 .

Digital Nerve Blockade in Raynaud ' s Disease

L. Fananapazir, 2005 .

Sudden cardiac death in hypertrophic cardiomyopathy.

B. Maron, L. Fananapazir, 1992, Circulation.

756-2 Long Term Results of Dual Chamber (DDD) Pacing in 114 Adult Patients with Obstructive Hypertrophic Cardiomyopathy and Severe Drug-Refractory Symptoms

L. Fananapazir, D. Mcareavey, 1995 .

Propafenone—Clinical Electrophysiology and Efficacy in Patients with Documented or Potentially Life‐threatening Arrhythmias

E. Prystowsky, L. Fananapazir, 1987 .

Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy.

V. Dilsizian, R. Bonow, S. Epstein, 1993, Journal of the American College of Cardiology.

Racial differences in the outcome of left ventricular dysfunction.

L. Fananapazir, D. Begley, S. Mohiddin, 1999 .

R403Q and L908V mutant β-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level

Matthew J. Tyska, Norman R. Alpert, David M. Warshaw, 2004, Journal of Muscle Research & Cell Motility.

Wolff-Parkinson-White syndrome and sudden cardiac death.

E. Prystowsky, D. Packer, L. Fananapazir, 1987, Cardiology.

The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy

J. Sellers, L. Fananapazir, N. Epstein, 1997, Journal of Muscle Research & Cell Motility.

Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.

L. Fananapazir, N. Epstein, H. Sweeney, 1995, The Journal of clinical investigation.

Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy.

D. Goldstein, L. Fananapazir, C. Tack, 2000, Journal of the American College of Cardiology.

Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death.

L. Fananapazir, D. Mcareavey, A. Chang, 1995, Current opinion in cardiology.

VT and sudden death in HCM patients.

S. Epstein, L. Fananapazir, 1989, Circulation.

The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy.

J. Sellers, L. Fananapazir, N. Epstein, 1997, Journal of muscle research and cell motility.

Regression of multiple pulmonary varices after mitral valve replacement.

L. Fananapazir, T. Shaw, A. Kitchin, 1980, The Journal of thoracic and cardiovascular surgery.

Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5-T magnetic resonance imaging scanning conditions.

C. Rinaldi, P. Woodard, L. Fananapazir, 2015, Heart rhythm.

Genomic organization, alternative splicing, and expression of human and mouse N-RAP, a nebulin-related LIM protein of striated muscle.

Saidi A Mohiddin, Lameh Fananapazir, L. Fananapazir, 2003, Cell motility and the cytoskeleton.

Advances in Understanding Hypertrophic Cardiomyopathy

L. Fananapazir, S. Mohiddin, Lameh Fananapazir, 2001, Hospital practice.

Atrial Synchronized Ventricular Pacing: Contribution of the Chronotropic Response to Improved Exercise Performance

D. Bennett, L. Fananapazir, LAMEH FANANAPAZIR, 1983, Pacing and clinical electrophysiology : PACE.

Suppression of Incessant Ventricular Tachycardia in Hypertrophic Cardiomyopathy Associated with Improvement of Severe Left Ventricular Dysfunction

L. Fananapazir, D. Mcareavey, 1992, Pacing and clinical electrophysiology : PACE.

Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone.

S. Epstein, L. Fananapazir, 1991, The American journal of cardiology.

Investigation and Clinical Significance of Arrhythmias in Patients with Hypertrophic Cardiomyopathy

S. Epstein, L. Fananapazir, N. Epstein, 1991 .

Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging

Daniel B Ennis, Peter Kellman, Andrew E Arai, 2003, Magnetic resonance in medicine.

Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.

L. Fananapazir, N. Epstein, 1994, Circulation.

Reversible Thallium-201 Abnormalities in Hypertrophic Cardiomyopathy

A. Quyyumi, V. Dilsizian, P. O'Gara, 2005 .

Differential effects of changes in local myocardial refractoriness on atrial and ventricular latency.

E. Prystowsky, D. Packer, L. Fananapazir, 1996, Circulation.

Results of valve replacement with the Omniscience prosthesis.

L. Fananapazir, D. B. Clarke, J. Dark, 1983, The Journal of thoracic and cardiovascular surgery.

Mitochondrial DNA mutations in the myelodysplastic syndrome

L. Fananapazir, M. Hochleitner, F. Gschnitzer, 2022 .